Search Results - (Author, Cooperation:A. Morandi)
-
1A. Ichimura ; A. Hirasawa ; O. Poulain-Godefroy ; A. Bonnefond ; T. Hara ; L. Yengo ; I. Kimura ; A. Leloire ; N. Liu ; K. Iida ; H. Choquet ; P. Besnard ; C. Lecoeur ; S. Vivequin ; K. Ayukawa ; M. Takeuchi ; K. Ozawa ; M. Tauber ; C. Maffeis ; A. Morandi ; R. Buzzetti ; P. Elliott ; A. Pouta ; M. R. Jarvelin ; A. Korner ; W. Kiess ; M. Pigeyre ; R. Caiazzo ; W. Van Hul ; L. Van Gaal ; F. Horber ; B. Balkau ; C. Levy-Marchal ; K. Rouskas ; A. Kouvatsi ; J. Hebebrand ; A. Hinney ; A. Scherag ; F. Pattou ; D. Meyre ; T. A. Koshimizu ; I. Wolowczuk ; G. Tsujimoto ; P. Froguel
Nature Publishing Group (NPG)
Published 2012Staff ViewPublication Date: 2012-02-22Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Adipocytes/metabolism/pathology ; Adipogenesis ; Adipose Tissue/metabolism/pathology ; Animals ; Calcium Signaling ; Cell Differentiation ; DNA Mutational Analysis ; Diet, High-Fat ; Energy Metabolism ; Europe/ethnology ; European Continental Ancestry Group/genetics ; Exons/genetics ; Fatty Liver/complications/genetics ; Gene Expression Regulation ; Glucagon-Like Peptide 1/secretion ; Glucose/metabolism ; Glucose Intolerance/complications ; Humans ; Insulin/metabolism ; Insulin Resistance ; Lipogenesis ; Liver/metabolism ; Macrophages/metabolism ; Mice ; Mutation/genetics ; Obesity/complications/genetics/*metabolism/pathology ; Receptors, G-Protein-Coupled/deficiency/genetics/*metabolism ; Signal Transduction/geneticsPublished by: -
2Autilio-Gambetti, L. ; Morandi, A. ; Tabaton, M. ; Schaetzle, B. ; Kovacs, D. ; Perry, G. ; Greenberg, B. ; Gambetti, P.
Amsterdam : ElsevierStaff ViewISSN: 0014-5793Keywords: (Cell culture) ; Alzheimer's disease ; Amyloid ; Amyloid precursor proteinSource: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: BiologyChemistry and PharmacologyPhysicsType of Medium: Electronic ResourceURL: -
3Massaro, A. R. ; Soranzo, C. ; Bigon, E. ; Battiston, S. ; Morandi, A. ; Carnevale, A. ; Callegaro, L.
Springer
Published 1994Staff ViewISSN: 1590-3478Keywords: Nerve growth factor (NGF) ; cerebrospinal fluid (CSF) ; neurological diseases ; multiple sclerosis (MS) ; amyotrophic lateral sclerosis (ALS)Source: Springer Online Journal Archives 1860-2000Topics: MedicineDescription / Table of Contents: Sommario È stato recentemente dimostrato che l'NGF non è solamente coinvolto nella sopravvivenza e lo sviluppo dei neuroni del sistema simpatico e in quelli sensitivi derivati dalla cresta neurale, ma anche in alcuni meccanismi del sistema immunitario. Per questo motivo abbiamo studiato il contenuto di NGF nel liquor di pazienti affetti da malattie quali la sclerosi multipla, la sclerosi laterale amiotrofica, la malattia di Alzheimer, le polineuropatie croniche recidivanti, la sindrome di Guillain-Barré e i tumori del sistema nervoso, nelle quali meccanismi neuroimmunologici paiono essere coinvolti, ed inoltre in un gruppo di soggetti neurologicamente sani presi come controlli. Abbiamo messo a punto una metodica ELISA per dosare la subunità beta dell'NGF, ottenendo buoni test di validazione e sensibilità fino a 28 pg βNGF per ml. Nessuno dei campioni conteneva livelli misurabili di NGF. Abbiamo quindi concentrato i campioni, ma soltanto un paziente ha presentato livelli significativi. Questo probabilmente mostra che l'NGF non è coinvolto nei meccanismi neuroimmunologici che potrebbero essere alla base di alcune malattie degenerative ed infiammatorie del sistema nervoso.Notes: Abstract It has been recently shown that NGF is not only involved in the survival and development of sympathetic and neural crest-derived sensory neurons, but also in some mechanisms of the immune system. For this reason, we studied the content of NGF in CSF samples from patients with diseases in which neuroimmonological mechanisms seem to be involved (multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer disease, chronic relapsing polyradiculoneuritis, Guillain-Barré syndrome, and tumors of the nervous system), as well as from a number of normal control subjects. We setup an ELISA aimed at the beta subunit of NGF, obtaining good validation tests and a detection limit of 28 pg βNGF per ml. None of the samples was found to contain detectable levels of NGF and, when a concentration method for sample enrichment was used, only one patient was NGF-positive. This suggests that NGF is probably not involved in the neuroimmunological mechanisms underlying some inflammatory and degenerative diseases of the nervous system.Type of Medium: Electronic ResourceURL: